ConductScience.org, home

Trial · NCT04931108

The Effect of Nitrendipine/Atenolol Combination on Blood Pressure Variability.

NCT04931108, Phase 4, Unknown, Shanghai Jiao Tong University School of Medicine

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. The Effect of Nitrendipine/Atenolol Combination on Blood Pressure Variability. Trials, record NCT04931108. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT04931108

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
The Effect of Nitrendipine/Atenolol Combination on Blood Pressure Variability.
NCT number
NCT04931108
Status
Unknown
Phases
Phase 4
Enrollment
32 participants, estimated
Lead sponsor
Shanghai Jiao Tong University School of Medicine
Conditions
Hypertension
Interventions
Nitrendipine/Atenolol, Nitrendipine, Atenolol
First posted
2021-06-18
Last updated
2023-04-14

Source ClinicalTrials.gov

Registered outcomes6

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryAmbulatory systolic blood pressure variability 1The first 6 weeks of treatment.Including the average real variability (ARV), the coefficient of variation (CV),and the standard deviation (SD).
PrimaryAmbulatory systolic blood pressure variability 2The second 6 weeks of cross-over treatment.Including the average real variability (ARV), the coefficient of variation (CV),and the standard deviation (SD).
SecondaryAmbulatory diastolic blood pressure variability 1The first 6 weeks of treatment.Including the average real variability (ARV), the coefficient of variation (CV),and the standard deviation (SD).
SecondaryAmbulatory diastolic blood pressure variability 2The second 6 weeks of cross-over treatment.Including the average real variability (ARV), the coefficient of variation (CV),and the standard deviation (SD).
SecondaryAmbulatory blood pressure 1The first 6 weeks of treatment.Including ambulatory blood pressure over 24 hours, daytime and nighttime.
SecondaryAmbulatory blood pressure 2The second 6 weeks of cross-over treatment.Including ambulatory blood pressure over 24 hours, daytime and nighttime.

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers1

The papers the trial lists on ClinicalTrials.gov.

PMIDListed as
39831760DERIVED

Source PubMed

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT04931108

GET https://conductscience.org/api/trials/v1/NCT04931108/registered